Shared Instrumentation Grant Program
Page 2

The types of research instruments that can be purchased under this program are nuclear magnetic resonance systems, electron and confocal microscopes, mass spectrometers, protein and DNA sequencers, biosensors, x-ray diffractometers and cell sorters.

The minimum cost of the instruments will be $100,000 each, and the maximum amount that will be granted per application will be $600,000.

The institutions and organizations that will be eligible to submit an application under the Shared Instrumentation Grant Program are the following:

a) Public/State Controlled Institutions of Higher Education

b) Private Institutions of Higher Education

c) Hispanic-serving Institutions

d) Historically Black Colleges and Universities (HBCUs)

e) Tribally Controlled Colleges and Universities (TCCUs)

f) Alaska Native and Native Hawaiian Serving Institutions

g) Nonprofit Organizations Other Than Institutions of Higher Education

The Department of Health and Human Services, the mother agency that is funding the Shared Instrumentation Grant Program, is the nation's principal agency that is largely responsible for protecting the health of all Americans and ensuring the provision of fundamental health and human services to all people needing such services.

Shared Instrumentation Grant Program
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Identifying Heart, Lung, and Blood Disease-Causing Variants
The National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---